Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase. [electronic resource]
Producer: 20090519Description: 1194-203 p. digitalISSN:- 1098-6596
- Anti-HIV Agents -- pharmacology
- CD4-Positive T-Lymphocytes -- drug effects
- Catalytic Domain -- genetics
- Cell Line
- Cells, Cultured
- Drug Evaluation, Preclinical
- Drug Resistance, Viral
- Drug Synergism
- HIV Integrase -- genetics
- HIV Integrase Inhibitors -- chemistry
- HIV Protease Inhibitors -- pharmacology
- HIV-1 -- drug effects
- Humans
- Inhibitory Concentration 50
- Molecular Structure
- Mutation
- Protein Structure, Tertiary
- Recombinant Proteins -- metabolism
- Reverse Transcriptase Inhibitors -- pharmacology
- Sensitivity and Specificity
- T-Lymphocytes -- drug effects
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.